MOUNJARO 7.5MG

Price 12000.00 INR/ Number

Get a Price/Quote

MOUNJARO 7.5MG Specification

Type
Hand Operating Rotary Sand Sieving Machine

Material
Mild Steel

Capacity
1 to 2 TPH Ton

Computerized
No

Automatic Grade
Manual

Frequency (MHz)
60 Hrz Hertz (HZ)

Size
Screen Size: 900 mm

Width
Screen Width: 900 mm Millimeter (mm)

Weight
Approx. 100-120 kg Kilograms (kg)

Dimension (L*W*H)
Approx. 1800 x 900 x 1400 mm Millimeter (mm)

Sieve type
Rotary

Color
Red

Mounting type
Wheeled

Power source
Manual

Application
River sand

Structure
Steel frame

Operation
Hand operated

Screen material
Mild Steel

Finish
Glossy

Mesh size
4 mm

MOUNJARO 7.5MG Trade Information

Minimum Order Quantity
5 Number

Payment Terms
Cash in Advance (CID)

Supply Ability
10 Per Month

Delivery Time
5 Days

Main Domestic Market
All India

About MOUNJARO 7.5MG

Mounjaro 7.5mg is a once-weekly prescription subcutaneous injection containing the active ingredient tirzepatide, manufactured by Eli Lilly. [1, 2, 3]

Key Characteristics & Mechanism

Active Ingredient: Tirzepatide (7.5mg per dose / 0.5 mL solution). [1, 2]

Drug Class: Dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. [1, 2]

How it Works: It activates both GIP and GLP-1 receptors to stimulate insulin secretion when blood sugar is high, decrease liver sugar production, slow stomach emptying, and suppress appetite by signaling fullness to the brain. [1, 2, 3]

Administration: Self-administered subcutaneously (under the skin) once a week using a pre-filled pen device such as the KwikPen.

Medical Uses & Dosing Context

Indications: Used alongside diet and exercise to manage type 2 diabetes mellitus in adults and pediatric patients aged 10 and older, and to lower cardiovascular risks. It is also prescribed off-label or under regional licensing for chronic weight management in adults with obesity or overweight with related health conditions. [1, 2, 3]

Where 7.5mg Fits: It represents a mid-level step in the standard dose-escalation schedule. Treatment typically starts at 2.5mg weekly for 4 weeks, increases to 5mg, and then can move to 7.5mg (and higher up to a 15mg maximum) as directed by a healthcare provider

Tell us about your requirement